<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699840/bin/cam40002-0286-f4.jpg"/> </div> <div class="text-side"> <h1>Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma.</h1> <p>Immunostaining for endothelial cells and pericytes (A and C) and H&amp;E staining (B and D) of mouse adrenal tumors (A and B) and human neuroblastoma (C and D). In (A) and (C), the green signals indicate endothelial cells; and the red signals, α-SMA-positive pericytes. The arrows in (B) and (D) indicate stromal cells. Scale bar = 200 μm.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/23930205/" target="_blank">23930205</a></p><p>Type: Premalignant/Malignant, Category: Neural or neuroendocrine</p>
</div> </div></div></body></html>